线粒体平衡调节:在帕金森病中是一个有前途的治疗点
Meng-Fan Yao1, Tao Dang1, Hua-Jun Wang2
1Department of Clinical Pharmabcy, the Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang, Jiangsu 212001, China; College of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
Behavioural brain research
|December 16, 2023
概括
线粒体功能障碍是帕金森病 (PD) 发病的核心,影响神经元完整性. 了解这一作用可能会揭示PD药物恢复线粒体功能的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和莱维体,线粒体功能障碍与其发展有关.
- 患PD的遗传因素越来越多地与线粒体完整性有关,这突出了线粒体作为研究的关键领域.
- 尽管有研究,目前针对线粒体的PD药物显示出有限的临床疗效.
研究的目的:
- 阐明线粒体功能障碍在神经退行性疾病发病过程中的作用.
- 通过检查线粒体结构和功能来探索PD的潜在干预措施和治疗点.
- 为开发旨在恢复线粒体功能的新型PD药物提供见解.
主要方法:
- 对神经退行性疾病中线粒体结构和功能的现有文献的综述.
- 分析PD相关基因与线粒体完整性之间的关系.
- 检查针对PD中线粒体的当前治疗策略.
主要成果:
- 线粒体功能障碍是帕金森病和相关疾病的发病的一个重要因素.
- 与PD相关的基因直接或间接影响线粒体健康.
- 目前用于PD的线粒体向疗法尚未取得最佳的临床结果.
结论:
- 准线粒体功能对于PD治疗具有前途.
- 对线粒体机制的进一步研究对于开发有效的PD疗法至关重要.
- 了解线粒体功能障碍可以指导开发新药,以恢复神经退行性疾病中的线粒体健康.
相关概念视频
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Parkinson's Disease: Overview
556
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
556
Electron Transport Chain: Complex I and II
13.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.8K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Mitochondrial Membranes
10.9K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
10.9K
Mitochondria
13.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.1K


